What is Miracles?
Miracles operates as a specialized nonprofit entity at the intersection of medical technology and humanitarian aid. The organization is primarily focused on the advancement of eye banking and the development of sophisticated surgical technologies. By providing high-quality tissue preparations and custom autologous serum eye drops, Miracles serves as a vital link in the surgical supply chain. Their market position is defined by a commitment to collaborative research and donor engagement, which facilitates the distribution of sight-restoring materials to transplant partners worldwide. Through these efforts, the company effectively bridges the gap between clinical demand and the availability of essential ocular tissues.
How much funding has Miracles raised?
Miracles has raised a total of $2.1M across 2 funding rounds:
Debt
$1M
Debt
$1.1M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.1M led by PPP
Key Investors in Miracles
PPP
Public-Private Partnership
What's next for Miracles?
With the recent influx of capital, Miracles is well-positioned to accelerate its strategic initiatives in surgical innovation and global outreach. The organization is expected to prioritize the expansion of its tissue processing facilities and the enhancement of its logistical network to support a broader range of transplant partners. Furthermore, the investment will likely fuel ongoing research into autologous serum therapies, potentially setting new standards for personalized ocular care. As the nonprofit continues to navigate the complexities of the healthcare sector, its focus remains on scaling its impact while maintaining the highest standards of tissue safety and clinical efficacy, ultimately aiming to reduce the global backlog of individuals awaiting sight-restoring procedures.
See full Miracles company page
